Showing results (21-30 of 300) with videos related to
Sort By:
Pageof 30
Current Pharmaceutical Design|March 7, 2012
Estrogen receptor beta in cancer: an attractive target for therapyDaniela Gallo, Ilaria De Stefano, Maria Grazia Prisco, et al.Fertility and Sterility|August 25, 2009
Conservative surgical management of stage IA endometrial carcinoma for fertility preservationIvan Mazzon, Giacomo Corrado, Valeria Masciullo, et al.BMC Cancer|December 17, 2008
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcomeFrancesco Legge, Marco Petrillo, Vincenzo Adamo, et al.Gynecologic Oncology|March 18, 2008
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancerGabriella Ferrandina, Manuela Ludovisi, Giacomo Corrado, et al.Gynecologic Oncology|July 21, 2004
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case reportGian Franco Zannoni, Valerio Gallotta, Francesco Legge, et al.Pathology, Research and Practice|April 3, 2007
Glassy cell carcinoma of the endometrium: a case report and review of the literatureGabriella Ferrandina, Gian Franco Zannoni, Marco Petrillo, et al.BMC Cancer|June 28, 2006
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literatureGabriella Ferrandina, Vanda Salutari, Antonia Testa, et al.Expert Review of Anticancer Therapy|November 1, 2017
Optimizing treatment in recurrent epithelial ovarian cancerGiacomo Corrado, Vanda Salutari, Eleonora Palluzzi, et al.Archives of Gynecology and Obstetrics|February 15, 2008
A case of isolated ovarian recurrence from vulvar carcinomaGabriella Ferrandina, Marco Petrillo, Gian Franco Zannoni, et al.Therapeutics and Clinical Risk Management|October 20, 2010
Pegylated liposomal doxorubicin in the management of ovarian cancerGabriella Ferrandina, Giacomo Corrado, Angelo Licameli, et al.Pageof 30